F2RL1 antibody
Quick Overview for F2RL1 antibody (ABIN7637063)
Target
See all F2RL1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- Polyclonal Antibody to Protease Activated Receptor 2 (PAR2)
-
Specificity
- The antibody is a rabbit polyclonal antibody raised against PAR2. It has been selected for its ability to recognize PAR2 in immunohistochemical staining and western blotting.
-
Purification
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
Immunogen
- RPA852Ra01Recombinant Protease Activated Receptor 2 (PAR2)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blotting: 0.5-2 μg/mLImmunohistochemistry: 5-20 μg/mLImmunocytochemistry: 5-20 μg/mLOptimal working dilutions must be determined by end user.
-
Comment
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 500 μg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
-
-
- F2RL1 (Coagulation Factor II (thrombin) Receptor-Like 1 (F2RL1))
-
Alternative Name
- PAR2
-
Background
- F2RL1, F2-RL1, GPR11, PAR2, Coagulation Factor II(thrombin)receptor-Like 1, G-protein coupled receptor 11, Thrombin receptor-like 1
-
UniProt
- Q63645
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, SARS-CoV-2 Protein Interactome
Target
-